Compare Applovin Corporation (APP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applovin Corporation vs GeneDx Holdings Corp — how do they compare? Applovin Corporation trades at $319.93 (market cap $106.65B), while GeneDx Holdings Corp trades at $81.66 (market cap $2.44B). The key difference: Applovin Corporation is far larger — about 43.7× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.
| APP | WGS | |
|---|---|---|
Market Cap | $106.65B | $2.44B |
Sector | Technology | Technology |
52-Week High | $733.60 | $167.51 |
52-Week Low | $318.68 | $34.51 |
Enterprise Value | $107.11B | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applovin Corporation
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
